756
Views
7
CrossRef citations to date
0
Altmetric
Review Article

Skin diseases of the vulva: inflammatory, erosive-ulcerating and apocrine gland diseases, zinc and vitamin deficiency, vulvodynia and vestibulodynia

&
Pages 149-160 | Received 01 Oct 2016, Accepted 15 Apr 2017, Published online: 01 Aug 2017

References

  • Ackerman AB. 1972. Focal acantholytic dyskeratosis. Archives of Dermatology 106:702–706.
  • Albers SE, Taylor G, Huyer D, Oliver G, Krafchik BR. 2000. Vulvitis circumscripta plasmacellularis mimicking child abuse. Journal of the American Academy of Dermatology 42:1078–1080.
  • Alikhan A, Lynch PJ, Eisen DB. 2009. Hidradenitis suppurativa: a comprehensive review. Journal of the American Academy of Dermatology 60:539–561.
  • Barret M, de Parades V, Battistella M, Sokol H, Lemarchand N, Marteau P. 2014. Crohn’s disease of the vulva. Journal of Crohn’s & Colitis 8:563–570.
  • Barthelemy H, Chouvet B, Cambazard F. 1986. Skin and mucosal manifestations in vitamin deficiency. Journal of the American Academy of Dermatology 15:1263–1274.
  • Bergeron S, Binik YM, Khalife S, Pagidas K, Glazer HI, Meana M, et al. 2001. A randomized comparison of group cognitive-behavioral therapy, surface electromyographic biofeedback, and vestibulectomy in the treatment of dyspareunia resulting from vulvar vestibulitis. Pain 91:297–306.
  • Bergeron S, Khalife S, Glazer HI, Binik YM. 2008. Surgical and behavioral treatments for vestibulodynia: two-and-one-half year follow-up and predictors of outcome. Obstetrics and Gynecology 111:159–166.
  • Bornstein J, Tuma R, Farajun Y, Azran A, Zarfati D. 2010. Topical nifedipine for the treatment of localized provoked vulvodynia: a placebo-controlled study. The Journal of Pain 11:1403–1409.
  • Bouchard C, Brisson J, Fortier M, Morin C, Blanchette C. 2002. Use of oral contraceptive pills and vulvar vestibulitis: a case-control study. American Journal of Epidemiology 156:254–261.
  • Brown CS, Wan J, Bachmann G, Rosen R. 2009. Self-management, amitriptyline, and amitripyline plus triamcinolone in the management of vulvodynia. Journal of Womens Health (Larchmt) 18:163–169.
  • Burge SM, Frith PA, Juniper RP, Wojnarowska F. 1989. Mucosal involvement in systemic and chronic cutaneous lupus erythematosus. The British Journal of Dermatology 121:727–741.
  • Burge SM. 1989. Darier’s disease and other dyskeratoses: response to retinoids. Pharmacology & Therapeutics 40:75–90.
  • Burge SM. 1992. Hailey–Hailey disease: the clinical features, response to treatment and prognosis. The British Journal of Dermatology 126:275–282.
  • Carli P, Cattaneo A, De Magnis A, Biggeri A, Taddei G, Giannotti B. 1995. Squamous cell carcinoma arising in vulval lichen sclerosus: a longitudinal cohort study. European Journal of Cancer Prevention 4:491–495.
  • Chi CC, Kirtschig G, Baldo M, Brackenbury F, Lewis F, Wojnarowska F. 2011. Topical interventions for genital lichen sclerosus. Cochrane Database of Systematic Review 2011:CD008240.
  • Chiesa-Vottero A, Dvoretsky PM, Hart WR. 2006. Histopathologic study of thin vulvar squamous cell carcinomas and associated cutaneous lesions: a correlative study of 48 tumors in 44 patients with analysis of adjacent vulvar intraepithelial neoplasia types and lichen sclerosus. The American Journal of Surgical Pathology 30:310–318.
  • Colombel JF, Sandborn WJ, Rutgeerts P, Enns R, Hanauer SB, Panaccione R, et al. 2007. Adalimumab for maintenance of clinical response and remission in patients with Crohn’s disease: the CHARM trial. Gastroenterology 132:52–65.
  • Cooper PH. 1989. Acantholytic dermatosis localized to the vulvocrural area. Journal of Cutaneous Pathology 16:81–84.
  • Cooper SM, Gao XH, Powell JJ, Wojnarowska F. 2004. Does treatment of vulvar lichen sclerosus influence its prognosis? Archives of Dermatology 140:702–706.
  • Cooper SM, Wojnarowska F. 2006. Influence of treatment of erosive lichen planus of the vulva on its prognosis. Archives of Dermatology 142:289–294.
  • Davis J, Shapiro L, Baral J. 1983. Vulvitis circumscripta plasmacellularis. Journal of the American Academy of Dermatology 8:413–416.
  • Dittmer CJ, Hornemann A, Rose C, Diedrich K, Thill M. 2010. Successful laser therapy of a papular acantholytic dyskeratosis of the vulva: case report and review of literature. Archives of Gynecology and Obstetrics 281:723–725.
  • Eisen D. 1999. The evaluation of cutaneous, genital, scalp, nail, esophageal, and ocular involvement in patients with oral lichen planus. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics 88:431–436.
  • Fischer G, Rogers M. 2000. Vulvar disease in children: a clinical audit of 130 cases. Pediatric Dermatology 17:1–6.
  • Fistarol SK, Itin PH. 2013. Diagnosis and treatment of lichen sclerosus: an update. American Journal of Clinical Dermatology 14:27–47.
  • Foster DC, Kotok MB, Huang LS, Watts A, Oakes D, Howard FM, et al. 2010. Oral desipramine and topical lidocaine for vulvodynia: a randomized controlled trial. Obstetrics and Gynecology 116:583–593.
  • Gerard AJ, Feldman SR, Strowd L. 2015. Quality of life of patients with pyoderma gangrenosum and hidradenitis suppurativa. Journal of Cutaneous Medicine and Surgery 19:391–396.
  • Goldstein AT, Anhalt GJ, Klingman D, Burrows LJ. 2005a. Mucous membrane pemphigoid of the vulva. Obstetrics and Gynecology 105:1188–1190.
  • Goldstein AT, Marinoff SC, Christopher K, Srodon M. 2005b. Prevalence of vulvar lichen sclerosus in a general gynecology practice. The Journal of Reproductive Medicine 50:477–480.
  • Guenther LC, Shum D. 1990. Localized childhood vulvar pemphigoid. Journal of the American Academy of Dermatology 22:762–764.
  • Gunther C, Wozel G, Meurer M, Pfeiffer C. 2004. Topical tacrolimus treatment for cicatricial pemphigoid. Journal of the American Academy of Dermatology 50:325–326.
  • Holst VA, Fair KP, Wilson BB, Patterson JW. 2000. Squamous cell carcinoma arising in Hailey–Hailey disease. Journal of the American Academy of Dermatology 43:368–371.
  • Hoque SR, Patel M, Farrell AM. 2006. Childhood cicatricial pemphigoid confined to the vulva. Clinical and Experimental Dermatology 31:63–64.
  • Jeon Y, Kim Y, Shim B, Yoon H, Park Y, Shim B, et al. 2013. A retrospective study of the management of vulvodynia. Korean Journal of Urology 54:48–52.
  • Jones RW, Sadler L, Grant S, Whineray J, Exeter M, Rowan D. 2004. Clinically identifying women with vulvar lichen sclerosus at increased risk of squamous cell carcinoma: a case-control study. The Journal of Reproductive Medicine 49:808–811.
  • Jorizzo JL, Schmalstieg FC, Solomon AR Jr, Cavallo T, Taylor RS III, Rudloff HB, et al. 1986. Thalidomide effects in Behçet’s syndrome and pustular vasculitis. Archives of Internal Medicine 146:878–881.
  • Kapila S, Bradford J, Fischer G. 2012. Vulvar psoriasis in adults and children: a clinical audit of 194 cases and review of the literature. Journal of Lower Genital Tract Disease 16:364–371.
  • Kartamaa M, Reitamo S. 1992. Familial benign chronic pemphigus (Hailey–Hailey disease). Treatment with carbon dioxide laser vaporization. Archives of Dermatology 128:646–648.
  • Kimball AB, Kerdel F, Adams D, Mrowietz U, Gelfand JM, Gniadecki R, et al. 2012. Adalimumab for the treatment of moderate to severe hidradenitis suppurativa: a parallel randomized trial. Annals of Internal Medicine 157:846–855.
  • Kirtschig G, Van Der Meulen AJ, Ion Lipan JW, Stoof TJ. 2002. Successful treatment of erosive vulvovaginal lichen planus with topical tacrolimus. The British Journal of Dermatology 147:625–626.
  • Lee A, Bradford J, Fisher G. 2015. Long-term management of adult vulvar lichen sclerosus: a prospective cohort study of 507 women. JAMA Dermatology 151:1061–1067.
  • Lever WF. 1979. Pemphigus and pemphigoid. A review of the advances made since 1964. Journal of the American Academy of Dermatology 1:2–31.
  • Lynch PJ, Moyal-Baraco M, Scurry J, Stockdale C. 2011. 2011 ISSVD terminology and classification of vulvar dermatological disorders: an approach to clinical diagnosis. Journal of Lower Genital Tract Disease 16:339–344.
  • Marzano AV, Ishak RS, Lazzari R, Polloni I, Vettoretti S, Crosti C. 2012. Vulvar pyoderma gangrenosum with renal involvement. European Journal of Dermatology: EJD 22:537–539.
  • Miyachi Y, Taniguchi S, Ozaki M, Horio T. 1981. Colchicine in the treatment of the cutaneous manifestations of Behçet’s disease. The British Journal of Dermatology 104:67–69.
  • Neill SM, Lewis FM, Tatnall FM, Cox NH. 2010. British Association of Dermatologists' guidelines for the management of lichen sclerosus 2010. The British Journal of Dermatology 163:672–682.
  • Nyirjesy P, Sobel JD, Weitz MV, Leaman DJ, Small MJ, Gelone SP. 2001. Cromolyn cream for recalcitrant idiopathic vulvar vestibulitis: results of a placebo controlled study. Sexually Transmitted Infections 77:53–57.
  • Pagano R, Wong S. 2012. Use of amitriptyline cream in the management of entry dyspareunia due to provoked vestibulodynia. Journal of Lower Genital Tract Disease 16:394–397.
  • Patton LW, Elgart ML, Williams CM. 1990. Vulvar erythema and induration. Extraintestinal Crohn’s disease of the vulva. Archives of Dermatology 126:1351.
  • Pelisse M. 1989. The vulvo-vaginal-gingival syndrome. A new form of erosive lichen planus. International Journal of Dermatology 28:381–384.
  • Petersen CD, Giraldi A, Lundvall L, Kristensen E. 2009. Botulinum toxin type A—a novel treatment for provoked vestibulodynia? Results from a randomized, placebo controlled, double blinded study. The Journal of Sexual Medicine 6:2523–2537.
  • Pock L, Svrckova M, Machackova R, Hercogova J. 2006. Pimecrolimus is effective in Fox–Fordyce disease. International Journal of Dermatology 45:1134–1135.
  • Pomerantz RG, Husni ME, Mody E, Qureshi AA. 2007. Adalimumab for treatment of pyoderma gangrenosum. The British Journal of Dermatology 157:1274–1275.
  • Powell J, Wojnarowska F. 2001. Childhood vulvar lichen sclerosus: an increasingly common problem. Journal of the American Academy of Dermatology 44:803–806.
  • Reed BD, Haefner HK, Sen A, Gorenflo DW. 2008. Vulvodynia incidence and remission rates among adult women: a 2-year follow-up study. Obstetrics and Gynecology 112:231–237.
  • Reed BG, Shippey S, Kremp A, Belin E. 2013. Vulvar pyoderma gangrenosum originating from a healed obstetric laceration. Obstetrics and Gynecology 122:452–455.
  • Regauer S, Reich O, Eberz B. 2014. Vulvar cancers in women with vulvar lichen planus: a clinicopathological study. Journal of the American Academy of Dermatology 71:698–707.
  • Rhode JM, Burke WM, Cederna PS, Haefner HK. 2008. Outcomes of surgical management of stage III vulvar hidradenitis suppurativa. The Journal of Reproductive Medicine 53:420–428.
  • Romero-Gomez M, Sanchez-Munoz D. 2002. Infliximab induces remission of pyoderma gangrenosum. European Journal of Gastroenterology & Hepatology 14:907.
  • Roy DB, Conte ET, Cohen DJ. 2006. The treatment of pyoderma gangrenosum using etanercept. Journal of the American Academy of Dermatology 54:S128–S134.
  • Rutgeerts P, D'Haens G, Targan S, Vasiliauskas E, Hanauer SB, Present DH, et al. 1999. Efficacy and safety of retreatment with anti-tumor necrosis factor antibody (infliximab) to maintain remission in Crohn’s disease. Gastroenterology 117:761–769.
  • Sand FL, Thomsen SF. 2013. Efficacy and safety of TNF-α inhibitors in refractory primary complex aphthosis: a patient series and overview of the literature. The Journal of Dermatological Treatment 24:444–446.
  • Satoh M, Yamamoto T. 2013. Genital pyoderma gangrenosum: report of two cases and published work review of Japanese cases. The Journal of Dermatology 40:840–843.
  • Schreiner DT, Jorizzo JL. 1987. Behçet’s disease and complex aphthosis. Dermatologic Clinics 5:769–778.
  • Sharquie KE. 1984. Suppression of Behçet’s disease with dapsone. The British Journal of Dermatology 110:493–494.
  • Shelley WB, Levy EJ. 1956. Apocrine sweat retention in man. II. Fox–Fordyce disease (apocrine miliaria). A.M.A. Archives of Dermatology 73:38–49.
  • Shelley WB, Pillsbury DM. 1959. Specific systemic antibiotic therapy in familial benign chronic pemphigus. Archives of Dermatology 80:554–556.
  • Smith SD, Fischer G. 2009. Childhood onset vulvar lichen sclerosus does not resolve at puberty: a prospective case series. Pediatric Dermatology 26:725–729.
  • Stashower ME, Krivda SJ, Turiansky GW. 2000. Fox–Fordyce disease: diagnosis with transverse histologic sections. Journal of the American Academy of Dermatology 42:89–91.
  • Tommola P, Unkila-Kallio L, Paavonen J. 2011. Long-term follow up of posterior vestibulectomy for treating vulvar vestibulitis. Acta Obstetricia Et Gynecologica Scandinavica 90:1225–1231.
  • Tommola P, Unkila-Kallio L, Paavonen J. 2012. Long-term well-being after surgical or conservative treatment of severe vulvar vestibulitis. Acta Obstetricia Et Gynecologica Scandinavica 91:1086–1093.
  • Venning VA, Frith PA, Bron AJ, Millard PR, Wojnarowska F. 1988. Mucosal involvement in bullous and cicatricial pemphigoid. A clinical and immunopathological study. The British Journal of Dermatology 118:7–15.
  • Vettraino IM, Merritt DF. 1995. Crohn’s disease of the vulva. The American Journal of Dermatopathology 17:410–413.
  • Vieira-Baptista P, Lima-Silva J, Cavaco-Gomes J, Beires J. 2014. Prevalence of vulvodynia and risk factors for the condition in Portugal. International Journal of Gynaecology and Obstetrics 127:283–287.
  • von Felbert V, Hampl M, Talhari C, Engers R, Megahed M. 2010. Squamous cell carcinoma arising from a localized vulval lesion of Hailey–Hailey disease after tacrolimus therapy. American Journal of Obstetrics and Gynecology 203:e5–e7.
  • Wang C, Lin A. 2014. Efficacy of topical calcineurin inhibitors in psoriasis. Journal of Cutaneous Medicine and Surgery 18:8–14.
  • Wieselthier JS, Pincus SH. 1993. Hailey–Hailey disease of the vulva. Archives of Dermatology 129:1344–1345.
  • Yoganathan S, Bohl TG, Mason G. 1994. Plasma cell balanitis and vulvitis (of Zoon). A study of 10 cases. The Journal of Reproductive Medicine 39:939–944.
  • Zamirska A, Reich A, Berny-Moreno J, Salomon J, Szepietowski JC. 2008. Vulvar pruritus and burning sensation in women with psoriasis. Acta Dermato-Venereologica 88:132–135.
  • Zouboulis CC, Desai N, Emtestam L, Hunger RE, Ioannides D, Juhasz I, et al. 2015. European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa. Journal of the European Academy of Dermatology and Venereology: JEADV 29:619–644.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.